Protein Degraders and Molecular Glues – Part 1

Paid

A new generation of molecules are being developed to disrupt protein-protein interactions and to hijack the cell’s natural machinery for targeted protein degradation. Proteolysis-targeting chimeras (PROTACs), molecular glues, and other modalities are utilizing the ubiquitin-proteasome, lysosome, and autophagy systems to seek out previously “undrugg

26-27 September 2023

Healthcare

Genomics-Driven Drug Discovery

Paid

While finding novel druggable targets and drug modalities for therapeutic intervention remains a top priority for the pharma/biotech industry, identifying and validating "good" targets and leads remains challenging. Cambridge Healthtech Institute’s conference on Genomics-Driven Drug Discovery discusses the use of functional genomics screening, gene

27-28 September 2023

Healthcare